Why 70% of Dermatology Practices Are Switching Billing Companies in 2026

Sirius solutions global
4 days ago
10 min read

Updated: 3 days ago

Free Demo

70%

of dermatology practices report dissatisfaction with their billing company

$6,900

average monthly revenue lost to preventable billing errors per provider

18–30%

typical revenue improvement when switching to specialty-focused billing

Think about this for a moment. A dermatology clinic seeing 45 patients a day a full schedule, steady referrals, a well-regarded provider team. By any external measure, the practice looks like it's thriving. And then the monthly revenue report comes in.

The numbers don't add up. You ran more patients this month than last month. You performed more procedures. The clinical team is at capacity. But collections are flat. A/R is creeping up. And the billing company's response when you ask about it? 'Denials have been higher this quarter across all our clients.'

If that scenario sounds familiar, you're not dealing with a slow season or a difficult payer. You're dealing with a billing relationship that isn't working and the financial damage is compounding every month that nothing changes.

Most dermatology practices don't need more patients. They need billing that actually captures the revenue the patients they already see are generating.

There's a reason dermatology practices across the country are switching billing companies at an accelerating rate in 2026. It's not that the old vendors are getting worse it's that the billing environment has gotten dramatically more complex, and the vendors who were adequate three years ago are genuinely struggling to keep up with what dermatology requires today.

This article breaks down exactly why that shift is happening — and what the practices making the switch are finding on the other side.

Why 2026 Is Different — The Structural Shift in Dermatology Billing

The forces reshaping dermatology billing in 2026 didn't arrive overnight. They've been building for several years. But 2026 is the year the pressure has become impossible for most practices to absorb passively.

The practices navigating this environment successfully aren't doing it with the same billing approach they used in 2022. The ones that are struggling the ones quietly leaking revenue, absorbing denials, and watching A/R drift upward largely are.

This isn't a billing trend. It's a structural shift in what it takes to get paid correctly in dermatology. And the billing company that was adequate three years ago may not be equipped for what dermatology billing requires today.

The Seven Reasons Dermatology Practices Are Switching Billing Companies

When we look at why practices finally make the decision to change — after months or years of suspecting something wasn't right — the same patterns emerge again and again.

01	Hidden Revenue Leakage That Nobody's Flagging
●	The Reality: Undercoding, missed modifiers, and billing code bundling errors are producing consistent revenue losses that never appear as a 'denial' — they just result in lower reimbursements than the documented clinical complexity supports. A complex excision with multilayer closure billed as a simple repair. An E/M visit on a procedure day billed without modifier -25, so the visit gets dropped entirely. These errors don't show up on a denial report; they show up as a vague feeling that collections don't match workload.
!	Financial Impact: For a practice billing 1,500+ encounters monthly, systematic undercoding by even one E/M level per visit represents $8,000–$15,000 in monthly revenue erosion. This money was earned and documented — it just wasn't billed correctly.
➔	Warning Signal: If your monthly collections feel consistently lower than your patient volume and procedure complexity justify — and you can't get a clear explanation from your billing company — revenue leakage through undercoding is almost certainly part of the story.

02	Denial Rates That Have Normalized at the Wrong Level
●	The Reality: A first-pass denial rate of 14–22% has become 'normal' in some dermatology billing operations. It shouldn't be. Industry benchmarks for well-managed dermatology billing are 5–8%. The gap between those numbers — when multiplied across monthly claim volume — represents a significant labor cost in rework and a meaningful revenue risk in claims that never get successfully appealed.
!	Financial Impact: Every denied claim costs $35–$85 in rework time. In a practice with a 15% denial rate on 800 monthly claims, that's 120 denials per month — $4,200–$10,200 in pure administrative cost before counting revenue delayed or lost on claims that don't get successfully worked.
➔	Warning Signal: Ask your billing company for a monthly breakdown of denial reasons by payer and by code type. If you can't get that report — or if the answer is 'denials have been higher industry-wide' without specifics — your billing team isn't doing root-cause analysis, and the same errors are repeating every month.

03	Generalist Billing Knowledge Failing Specialty Complexity
●	The Reality: Dermatology billing requires specialized knowledge that general medical billing companies simply don't maintain at the required depth. Correct modifier sequencing for multi-procedure visits. Current bundling rules for excision plus repair codes. Biologic prior authorization documentation requirements for each major payer. Cosmetic versus medical billing distinctions for laser and light-based procedures. A billing team handling dermatology alongside cardiology and orthopedics isn't going to stay current on all of it.
!	Financial Impact: When a generalist billing team misses a biologic PA renewal, the practice loses the entire course of therapy revenue — sometimes $4,000–$8,000+ per patient per treatment cycle. When Mohs procedure codes are billed without current awareness of payer-specific stage documentation requirements, the claims get denied or reduced and staff don't understand why.
➔	Warning Signal: If your billing company can't immediately tell you the step therapy documentation requirements for your top two commercial payers' biologic approvals — or explain current NCCI bundling rules for excision plus adjacent tissue repair — you don't have specialty dermatology expertise on your account.

04	Compliance and Audit Exposure Nobody's Managing
●	The Reality: Dermatology has become one of the higher-audit-risk specialties under both Medicare and commercial payer scrutiny. Mohs surgery stage billing. Biologic authorization compliance. The cosmetic-versus-medical line on procedures like chemical peels, laser resurfacing, and excisions. These are actively reviewed categories. Practices whose billing teams aren't running regular internal audits and maintaining audit-trail documentation are accruing risk that will eventually surface in a payer review.
!	Financial Impact: Post-payment audit recoupment demands in dermatology can reach five to six figures when systematic billing issues are identified over a multi-year look-back. The cost of an audit response — legal fees, staff time, prepayment suspension — adds to the financial damage on top of any repayment obligation.
➔	Warning Signal: When did your billing company last conduct an internal audit of your claims against current payer documentation requirements? If the answer is 'never' or 'we don't know,' you have a compliance gap that a payer may find before you do.

05	Scaling Pain as Practice Volume or Complexity Grows
●	The Reality: Billing complexity in dermatology doesn't scale linearly. When you add a second provider, open a satellite location, or start a medical spa offering, billing complexity grows at a faster rate than patient volume. A billing operation that handled a single-provider practice acceptably may be completely overwhelmed by a two-provider, multi-location practice — and the revenue performance degrades proportionally.
!	Financial Impact: Practices that add clinical capacity without adding equivalent billing capability often see their per-visit collection rate drop even as total volume increases. The revenue-per-provider metric tells the story: if it's declining as the practice grows, the billing infrastructure hasn't kept up.
➔	Warning Signal: If your practice has grown by 30% in the past two years but revenue has grown by 15%, the gap is almost certainly your billing. That's not a market problem or a payer problem — it's a billing performance problem.

06	Billing Companies That Submit Claims Instead of Optimizing Revenue
●	The Reality: There's a meaningful difference between a vendor that submits claims and a partner that manages revenue. Submitting claims means entering codes, sending to payer, and waiting. Managing revenue means pre-submission validation, denial pattern analysis, regular coding reviews against current payer requirements, proactive prior authorization tracking, and monthly performance reporting that tells you something useful. Many dermatology practices realize — often after years — that what they have is a claim submission service, not revenue cycle management.
!	Financial Impact: The difference in annual collections between a billing operation that submits claims and one that actively manages revenue cycle performance is typically 12–22% of total collectible revenue. For a $1.5M practice, that's $180,000–$330,000 in year-over-year revenue difference.
➔	Warning Signal: Does your billing company send you a monthly report that includes denial rate by payer, top denial reasons by code type, A/R aging by payer bucket, and first-pass clean claim rate? If not, ask for it. What you receive — or don't — will tell you a lot about the nature of the service you're actually paying for.

07	No Transparency and No Accountability on Performance
●	The Reality: One of the most common complaints from practices that have switched billing companies is a simple one: they could never get clear answers. Monthly revenue totals, yes. But denial rate broken down by payer and by procedure type? Hard to get. Explanation for why a specific code category is performing below benchmark? The question gets deflected. Root-cause analysis on why the same denial reason keeps appearing month after month? Nobody seems to be doing it.
!	Financial Impact: Lack of reporting transparency isn't just an inconvenience. It's a structural problem that prevents practices from identifying and addressing billing performance issues. When you can't see your numbers in detail, you can't manage what isn't working — and your billing vendor has no accountability for improving it.
➔	Warning Signal: A high-performing billing partner proactively shares performance data with you before you have to ask for it. If getting a detailed billing report from your current company requires repeated requests and still produces vague responses, that relationship is costing you money that better visibility would allow you to recover.

A Closer Look at the Revenue Leaks — Quantified

It's one thing to say revenue is leaking. It's more useful to know where and roughly how much. Here are the major revenue leak sources in dermatology billing and what they typically cost a mid-size practice monthly.

An important note: these leaks don't all appear as denials. A significant portion particularly undercoding and missed modifiers result in lower reimbursements than the documented clinical complexity supports, without generating any denial event. That's why practices often don't connect the billing problem to the revenue gap. The claim paid. Just not for what it should have.

What Dermatology Practices Are Finding When They Switch

The practices making the move to specialty-focused dermatology billing partners aren't doing it because they were sold on a pitch. They're doing it because the performance difference became impossible to rationalize away.

What practices typically report after switching: A meaningful increase in first-pass clean claim rates within 60 days. A measurable reduction in denial rate within 90 days. And within one billing cycle, discovery of revenue streams — undercoded visits, missed charge categories, uncaptured CCM billing — that hadn't been captured under the previous billing arrangement.

A Billing Company Accountability Checklist — For Your Current Relationship

Before making any decision about your billing partner, it's worth asking some direct questions. How your current company answers or whether they can answer at all will tell you more than any comparison chart.

Can you tell me our current first-pass clean claim rate this month?

What are our top three denial reasons by payer and by procedure code right now?

What is our average days in A/R by payer bucket?

Have you identified any undercoding patterns in our current claims?

How do you handle payer coverage rule updates — what is your process?

When did you last conduct an internal audit of our coding accuracy?

What percentage of our denied claims are successfully appealed?

What has changed in your management of our account in the last 90 days?

How to Score Your Answers

1. 8–10 confident Yes answers: Your billing company is performing. Consider whether the metrics match the confidence of their answers.

2. 5–7 Yes answers: There are visibility gaps in your revenue cycle. Whether that translates to financial loss depends on what those specific gaps contain.

3. Fewer than 5 Yes answers: You're flying without instrumentation. The revenue leakage is almost certainly real you just don't have the data to see where it's coming from or how much it's costing.

What Dermatology-Focused Billing Actually Looks Like

The practices that have made the switch and seen the biggest improvements share a common observation: the difference isn't primarily about technology or price. It's about working with a team that understands dermatology billing the way you understand dermatology medicine.

That means coders who know the difference between modifier -51 and -59 in a multi-procedure dermatology visit and when each applies. Billing specialists who understand what step therapy documentation a commercial payer actually requires for a Dupixent authorization not just that step therapy is required. A reporting structure that tells you something actionable, not just a total collections number.

What Sirius Solutions Global Brings to Dermatology Billing

✔ Dermatology-certified coders on every account. Not general coders who handle 10 specialties. Specialists trained specifically in dermatology coding — excisions, Mohs, biologics, laser and light procedures, and the cosmetic-versus-medical distinctions that payers scrutinize.

✔ AI-assisted pre-submission claim validation. Every claim is checked against current payer rules before it goes out. CPT/ICD-10 accuracy, modifier appropriateness, bundling compliance, authorization status — validated in real time, not discovered after denial.

✔ Proactive revenue recovery audits. We regularly review your claim patterns for undercoding, missed charge categories, and uncaptured billing opportunities — not just what was submitted, but what should have been.

✔ Full prior authorization lifecycle management. Biologic PA submissions, step therapy documentation, authorization tracking, renewal alerts, and escalation management — handled as a proactive workflow, not a reactive scramble.

✔ Transparent monthly reporting that drives decisions. Denial rate by payer, first-pass clean claim rate, A/R aging, top denial reasons by code type, and appeal success rate — every month, without having to ask.

✔ Realistic outcomes — not promises. Most practices working with us see first-pass clean claim rates above 93%, denial rates below 7%, and measurable revenue recovery from previously uncaptured billing within 60–90 days of onboarding.

The Honest Question Every Dermatology Practice Should Be Asking

Are you truly getting paid for the care you provide?

Not paid something paid accurately, completely, and at the rate the documented complexity of your encounters actually supports. That's a different question than 'are our claims going out?' And it's the question that's driving 70% of dermatology practices to take a harder look at their billing relationships in 2026.

The practices that are thriving financially right now aren't necessarily the busiest ones. They're the ones where billing performance has kept pace with clinical complexity where the revenue cycle is genuinely managed, not just administered.

If your practice feels busier than your revenue reflects if your billing company's answers to basic performance questions are vague, if your denial rate has been 'a little high' for more than two consecutive quarters the billing relationship is probably the explanation.

Find Out Where Your Revenue Is Actually Going

We offer a complimentary dermatology billing performance review — a clear, no-obligation analysis of your denial patterns, coding accuracy, and revenue recovery opportunities. Most practices discover something meaningful in the first conversation.

» Request Your Free Revenue Review → siriussolutionsglobal.com/specialties/dermatology-billing

Most practices don't need more patients. They need billing that actually captures the revenue the patients they already see are generating. That's the shift — and for the practices that make it, the financial impact typically shows up within a single billing cycle.

A busy practice and a profitable practice are not the same thing. Billing is the difference — and the right billing partner is the difference between adequate and optimal.

Free Demo

Sirius Solutions Global | Dermatology Billing Services

Revenue Cycle Management | Coding Accuracy | Denial Prevention | Prior Authorization Management

Specialty expertise. Transparent results. Revenue your practice keeps.